About MEAJO | Editorial board | Search | Ahead of print | Current Issue | Archives | Instructions to authors | Online submission | Subscribe | Advertise | Contact | Login 
Middle East African Journal of Ophthalmology Middle East African Journal of Ophthalmology
Users Online: 194   Home Print this page Email this page Small font sizeDefault font sizeIncrease font size

    Article Cited by others

SYMPOSIUM - OCULAR THERAPEUTICS OF THE FUTURE

Nanotechnology approaches for ocular drug delivery

Xu Qingguo, Kambhampati Siva P, Kannan Rangaramanujam M

Year : 2013| Volume: 20| Issue : 1 | Page no: 26-37

   This article has been cited by
 
1 Nanostructured lipid carriers: Promising drug delivery systems for future clinics
Ana Beloqui,María Ángeles Solinís,Alicia Rodríguez-Gascón,António J. Almeida,Véronique Préat
Nanomedicine: Nanotechnology, Biology and Medicine. 2016; 12(1): 143
[Pubmed]  [Google Scholar] [DOI]
2 Nanocrystal for ocular drug delivery: hope or hype
Om Prakash Sharma,Viral Patel,Tejal Mehta
Drug Delivery and Translational Research. 2016;
[Pubmed]  [Google Scholar] [DOI]
3 Preparation and In Vitro/In Vivo Evaluation of Cyclosporin A-Loaded Nanodecorated Ocular Implants for Subconjunctival Application
Sibel Bozdag Pehlivan,Burçin Yavuz,Semih Çalamak,Kezban Ulubayram,Abbas Kaffashi,Imran Vural,Hasan Basri Çakmak,Meltem Ezgi Durgun,Emir Baki Denkbas,Nursen Ünlü
Journal of Pharmaceutical Sciences. 2015; 104(5): 1709
[Pubmed]  [Google Scholar] [DOI]
4 Facets of Nanotechnology as Seen in Food Processing, Packaging, and Preservation Industry
Neha Pradhan,Surjit Singh,Nupur Ojha,Anamika Shrivastava,Anil Barla,Vivek Rai,Sutapa Bose
BioMed Research International. 2015; 2015: 1
[Pubmed]  [Google Scholar] [DOI]
5 Current nanotechnology approaches for the treatment and management of diabetic retinopathy
Joana F. Fangueiro,Amélia M. Silva,Maria L. Garcia,Eliana B. Souto
European Journal of Pharmaceutics and Biopharmaceutics. 2015; 95: 307
[Pubmed]  [Google Scholar] [DOI]
6 Nanoengineering of therapeutics for retinal vascular disease
Nivriti Gahlaut,Sandra Suarez,Md. Imam Uddin,Andrew Y. Gordon,Stephanie M. Evans,Ashwath Jayagopal
European Journal of Pharmaceutics and Biopharmaceutics. 2015; 95: 323
[Pubmed]  [Google Scholar] [DOI]
7 Drug-loaded nanocarriers for back-of-the-eye diseases- formulation limitations
Yoav Hamdi,Frederic Lallemand,Simon Benita
Journal of Drug Delivery Science and Technology. 2015; 30: 331
[Pubmed]  [Google Scholar] [DOI]
8 In vivo delivery of siRNA to the brain by carbosilane dendrimer
Mª Jesús Serramía,Susana Álvarez,Elena Fuentes-Paniagua,Maria Isabel Clemente,Javier Sánchez-Nieves,Rafael Gómez,Javier de la Mata,Mª Ángeles Muñoz-Fernández
Journal of Controlled Release. 2015; 200: 60
[Pubmed]  [Google Scholar] [DOI]
9 The role of nanotechnology in control of human diseases: perspectives in ocular surface diseases
Mahendra Rai,Avinash P. Ingle,Swapnil Gaikwad,Felipe Hering Padovani,Monica Alves
Critical Reviews in Biotechnology. 2015; : 1
[Pubmed]  [Google Scholar] [DOI]
10 Corticosteroid-loaded biodegradable nanoparticles for prevention of corneal allograft rejection in rats
Qing Pan,Qingguo Xu,Nicholas J. Boylan,Nicholas W. Lamb,David G. Emmert,Jeh-Chang Yang,Li Tang,Tom Heflin,Saeed Alwadani,Charles G. Eberhart,Walter J. Stark,Justin Hanes
Journal of Controlled Release. 2015; 201: 32
[Pubmed]  [Google Scholar] [DOI]
11 Shaping Magnetic Fields to Direct Therapy to Ears and Eyes
B. Shapiro,S. Kulkarni,A. Nacev,A. Sarwar,D. Preciado,D.A. Depireux
Annual Review of Biomedical Engineering. 2014; 16(1): 455
[Pubmed]  [Google Scholar] [DOI]
12 Cyclosporine A Loaded PLGA Nanoparticles for Dry Eye Disease: In Vitro Characterization Studies
Vijay D. Wagh,Dipak U. Apar
Journal of Nanotechnology. 2014; 2014: 1
[Pubmed]  [Google Scholar] [DOI]
13 Drug targeting using solid lipid nanoparticles
Elham Rostami,Soheila Kashanian,Abbas H. Azandaryani,Hossain Faramarzi,Jafar Ezzati Nazhad Dolatabadi,Kobra Omidfar
Chemistry and Physics of Lipids. 2014;
[Pubmed]  [Google Scholar] [DOI]
14 Nanocomposite-siRNA approach for down-regulation of VEGF and its receptor in myeloid leukemia cells
Lei Wang,Wen-jun Zhang,Bing Xiu,Yi Ding,Ping Li,Wei-de Ye,Qi Zhu,Ai-bin Liang
International Journal of Biological Macromolecules. 2014; 63: 49
[Pubmed]  [Google Scholar] [DOI]
15 Conducting polymer nanoparticles decorated with collagen mimetic peptides for collagen targeting
José Luis Santos,Yang Li,Heidi R. Culver,Michael S. Yu,Margarita Herrera-Alonso
Chem. Commun.. 2014; 50(95): 15045
[Pubmed]  [Google Scholar] [DOI]
16 Ocular therapeutics of the future
Yiu, S.C.
Middle East African Journal of Ophthalmology. 2013; 20(1): 1-2
[Pubmed]  [Google Scholar]
17 Efficacy and safety of dendrimer nanoparticles with coexpression of tumor necrosis factor-α and herpes simplex virus thymidine kinase in gene radiotherapy of the human uveal melanoma OCM-1 cell line
Wang Y, Mo L, Wei W, Shi X
International Journal of Nanomedicine. 2013; 8: 3805-3816
[Pubmed]  [Google Scholar]
18 In vitro and in vivo uptake study of Escherichia coli nissle 1917 bacterial ghosts: Cell-based delivery system to target ocular surface diseases
Stein E, Inic-Kanada A, Belij S, Najdenski H, Barisani-Asenbauer T
Investigative Ophthalmology and Visual Science. 2013; 54(9): 6326-6333
[Pubmed]  [Google Scholar]
19 Nanomedicine in cerebral palsy
Balakrishnan B, Nance E, Johnston MV, Kannan R, Kannan S
International Journal of Nanomedicine. 2013; 8: 4183-4195
[Pubmed]  [Google Scholar]

 

Read this article